SOPHiA GENETICS (SOPH) Short-term Investments (2020 - 2022)

SOPHiA GENETICS's Short-term Investments history runs 3 years deep, the most recent figure standing at $17.3 million for Q4 2022.

• In Q4 2022, Short-term Investments fell 76.08% year-over-year to $17.3 million; the TTM figure through Dec 2022 stood at $17.3 million (down 76.08% YoY), while the FY2022 annual figure was $17.3 million, down 76.08% from the prior year.
• Short-term Investments came in at $17.3 million for Q4 2022 at SOPHiA GENETICS, down from $72.4 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $72.4 million in Q4 2021 to a low of $17.3 million in Q4 2022.
• A 3-year average of $37.5 million and a median of $22.7 million in 2020 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments surged 218.47% in 2021 and plunged 76.08% in 2022, its largest moves.
• SOPHiA GENETICS's Short-term Investments stood at $22.7 million in 2020, then soared by 218.47% to $72.4 million in 2021, then slumped by 76.08% to $17.3 million in 2022.
• According to Business Quant data, Short-term Investments over the past three periods registered $17.3 million, $72.4 million, and $22.7 million for Q4 2022, Q4 2021, and Q4 2020 respectively.

Peer Comparison